Amina A. Baiomy
Department of Medical Biochemistry,
Lamiaa F. Arafa
Department of Medical Biochemistry,
Asaad A. Ghanem
Department of Ophthalmology,
Faculty of Medicine, Mansoura University, Egypt
ABSTRACT
The present study has to investigated the relationship between diabetic retinopathy and the levels of vascular endothelial growth factor and IL-6 in aqueous humor and plasma and also determination of VEGF gene expression. The current study was carried out on undiluted aqueous humor samples and the corresponding plasma samples of 24 diabetic patients (24 eyes) and 12 non diabetic patients (12 eyes) who underwent cataract surgery. VEGF and IL-6 were measured in aqueous humor and plasma samples by Enzyme Linked Immunosorbent Assay (ELISA) kits and total RNA content was measured and VEGF gene expression was analysed by RT-PCR. VEGF and IL-6 levels revealed a high significant rise in aqueous humor of diabetic patients and non-significant rise in plasma of the same patients. A high +ve correlation was found between VEGF and IL-6 in aqueous humor samples of diabetic patients. In addition, present results revealed increased expression of three molecular forms of VEGF (VEGF121, VEGF145, VEGF165) in diabetic patients. VEGF and IL-6 are produced together in the intraocular tissues and are involved in the pathogenesis of DR. VEGF gene expression is increased early in DR. So, anti-VEGF drugs may have future application for treatment of diabetic retinopathy.
PDF References Citation
How to cite this article
Amina A. Baiomy, Lamiaa F. Arafa and Asaad A. Ghanem, 2004. Relationship Between Vascular Endothelial Growth Factor and Interleukin-6 in Diabetic Retinopathy. Pakistan Journal of Biological Sciences, 7: 1858-1864.
DOI: 10.3923/pjbs.2004.1858.1864
URL: https://scialert.net/abstract/?doi=pjbs.2004.1858.1864
DOI: 10.3923/pjbs.2004.1858.1864
URL: https://scialert.net/abstract/?doi=pjbs.2004.1858.1864
REFERENCES
- Porta, M. and F. Bandello, 2002. Diabetic retinopathy: A clinical update. Diabetologia, 45: 1617-1634.
Direct Link - Jesus, R., E. Ayuso, M. Navarro, A. Carretero and F. Bosch, 2004. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes like eye disease. J. Clin. Invest., 113: 1149-1157.
Direct Link - Doganay, S., C. Evereklioglu, H. Er, Y. Turkoz, A. Sevine and N. Mehmet, 2002. Comparison of serum NO, TNF-alpha, IL-1 beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye, 16: 167-170.
Direct Link - Awata, T., K. Inoue, S. Kurihara, T. Ohkubo and M. Watanabe et al., 2002. A common polymorphism in the 5'-Untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 51: 1635-1639.
Direct Link - Duh, E. and L.P. Aiello, 1999. Vascular endothelial growth factor and diabetes: The agonist versus antogonist paradox. Diabetes, 48: 1899-1906.
Direct Link - Morohoshi, M., K. Fujisawa, I. Uchimura and F. Numano, 1996. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes, 45: 954-959.
Direct Link - Cohen, T., D. Nahari and T.W. Cerem, 1996. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271: 736-741.
Direct Link - Ray, D., M. Mishra, S. Ralph, I. Read, R. Davies and P. Brenchley, 2004. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes, 53: 861-864.
CrossRefDirect Link - Hyodo, I., T. Doi, H. Endo, Y. Hosokawa and Y. Kotoni, 1998. Clinical significance of plasma VEGF in gastrointestinal cancer. Eur. J. Cancer, 34: 2041-2045.
Direct Link - Brailly, H., F.A. Montero-Julian, C.E. Zuber, S. Flavetta, J. Grassi, F. Houssiau and J. van Snick, 1994. Total interleukin-6 in plasma measured by immunoassay. Clin. Chem., 40: 116-121.
Direct Link - Houch, K.A., N. Ferrara, J. Winer and D.W. Leung, 1991. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinal., 5: 1806-1814.
Direct Link - Klauspodar, F.E, L. Suzanne, S. Martin and K. Boris, 2001. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood, 98: 428-435.
Direct Link - De Vriese, A.S., T.J. Verbeuren, J. van de Voorde, N.H. Lameire and P.M. Vanhoutte, 2000. Endothelial dysfunction in diabetes. Br. J. Pharmacol., 130: 963-974.
PubMedDirect Link - Ikeda, T., 2003. The pathogenesis of vitreo-retinal diseases from the stand point of molecular biology. J. Jap. Ophthalmol. Soc., 107: 785-812.
Direct Link - Caldwell, R.B., M. Bartoli, M.A. Behzadian and R.W. Caldwell, 2003. Vascular endothelial growth factor and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Diabetics Metab. Res. Rev., 19: 442-455.
Direct Link - Song, E., Y. Dong, L.N. Han, D.M. Sui, Q. Xu, X.R. Wang and J.X. Wu, 2004. Diabetic retinopathy: VEGF, bFGF and retinal vascular pathology. Chin. Med. J., 117: 247-251.
PubMedDirect Link - Witmer, A.N., G.F. Vrensen, C.J. van Noorden and R.O. Schlingemann, 2003. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res., 22: 1-29.
PubMedDirect Link - Ideta, R., H. Yamashito, Y. Tanaka and S. Hori, 1999. Roles of cytokines in diabetic retinopathy. Arch Ophthalmol., 117: 700-701.
Direct Link - De vos, A.F., V.N.A Klaren and A. Kijlstra, 1994. Expression of multiple cytokines and IL-1 RA in the Uvea and retina during endotoxin-induced uveitis in the rat. Invest. Ophthalmol. Vis. Sci., 35: 3873-3883.
Direct Link - Kauffmann, D.J.H., J.C. van Meurs and D.A.E. Mertens, 1994. Cytokines in vitreous humor: Interleukin-6 elevated in vitreo retinopathy. Invest. Ophthalmol. Vis. Sci., 35: 900-906.
Direct Link - Sanchez, R.N., C.K. Chan, J.M. Kwong and T.T. Lam, 2003. Interleukin-6 in retinal ischemia reperfusion injury in rats. Invest. Ophthalmol. Vis. Sci., 44: 4006-4011.
Direct Link - Nakamura, N., G. Hasegawa, H. Obayashi and T. Ikeda, 2003. Increased concentration of pentosidine, an advanced glycation end product and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Res. Clin. Pract., 61: 93-101.
Direct Link - Yamamoto, H., H. Hayashi, H. Uchida, H. Kato and K. Oshima, 2003. Increased soluble interleukin-6 receptor in vitreous fluid of proliferative vitreoretinopathy. Curr. Eye Res., 26: 9-14.
Direct Link - Chen, K., W. Chih-Chiau, R. Sayon, L. Shui-Mei and L. Jorn-Hon, 1999. Increased interleukin-6 in aquous humor of neovascular glaucoma. Invest. Ophthalmol. Visual Sci., 40: 2627-2632.
Direct Link - Balasubramanyam, M., M. Rema and C. Premanand, 2002. Biochemical and molecular mechanisms of diabetic retinopathy. Current Sci., 83: 1506-1514.
Direct Link - Funatsu, H., H. Yamashita, H. Noma and S. Hori, 2002. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am. J. Ophthalmol., 133: 70-77.
Direct Link - Ikeda, U., Y. Meada, T. Takahashi and K. Shimada, 2000. Interaction between human monocytes and vascular smooth muscle cells induces VEGF expression. Atherosclerosis, 150: 63-70.
Direct Link - Noma, H., I. Sakamoto, H. Mochizuki, H. Tsukamoto and A. Minamoto et al., 2004. Relationship between periodontal disease and diabetic retinopathy. Diabetic Care, 27: 615-615.
Direct Link - Kim, I., A.M. Ryan and R. Rohan, 1999. Constitutive expression of VEGF, VEGFR-1 and VEGFR-2 in normal eyes. Invest. Ophthalmol. Vis. Sci., 40: 2115-2121.
Direct Link - Shweiki, D., A. Itin, D. Soffer and E. Keshet, 1992. VEGF induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359: 843-845.
Direct Link - Funatsu, M.D., M.D. Hipetoshi Yamashita, M.D. Erika Shimizu and S. Hori, 2001. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina, 21: 469-477.
Direct Link